EGFR-IN-60 exhibits potent and safe antitumor activity by inhibiting EGFRWT, EGFRT790M, EGFRL858R, and JAK3; it induces apoptosis through increasing the Bax/Bcl-2 ratio, leading to cell death; it shows good oral absorption and effectively inhibits tumor cell proliferation in H1975 (EGFRT790M-mutant) and A431 (EGFRWT-overexpressing) cells.